Tech Company Financing Transactions
UltraSight Funding Round
UltraSight, based in Cambridge, received $24 million from ALIVE Israel HealthTech Fund, Connecticut Innovations and Deep Insight.
Transaction Overview
Company Name
Announced On
9/23/2026
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds for the commercial expansion in the United States and development of new high-value workflows for the intensive care unit and circulatory support settings, where time-critical imaging decisions directly shape patient management.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
One Broadway, 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
We are a team of best-in-class AI engineers, clinicians, developers, and business experts united in our commitment to improve patient care by leveraging the power of AI. We believe that better patient care begins with having access to high-quality ultrasound images taken anywhere patients need them, whether it is the GP office or Emergency Department. By simplifying the process of cardiac sonography, we aim to expand patient access to timely cardiac care.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/23/2026: Hubble Network venture capital transaction
Next: 9/23/2026: braendz venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








